Detail akcie Quest Diagnostcs online

Business Summary: Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Quest Diagnostics Inc revenues decreased 6% to $9.25B. Net income applicable to common stockholders decreased 10% to $850M. Revenues reflect Diagnostic Information Services Business segment decrease of 7% to $8.98B. Net income also reflects Diagnostic Information Services Business segment income decrease of 9% to $1.55B, General corporate activities segment loss increase of 8% to $319M.